Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease

Details for Australian Patent Application No. 2008201881 (hide)

Owner Myriad Genetics, Inc.

Inventors Drix, Suzanne; Hobden, Adrian; Mather, Gary; Zavitz, Kenton

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008201881

Parent 2004311577

Filing date 28 April 2008

Wipo publication date 22 May 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/192 (2006.01)

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

15 May 2008 Complete Application Filed

22 May 2008 Application Open to Public Inspection

  Published as AU-A-2008201881

12 June 2008 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read FROM: Drix, Suzanne TO: Hendrix, Suzanne

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201882-Method and apparatus for estabishing a secure smart card communication link through a communication network

2008201880-Antiviral inhibitants of capsid proteins